Day One Biopharmaceuticals: ‘Strong Buy,’ Several 2026 Milestones In Play Plus OJEMDA Growth Mar 5, 2026
AbbVie wins FDA nod for Venclexta-acalabrutinib combo in first-line chronic lymphocytic leukemia Feb 20, 2026